Skip to main content

Chemical sphincterotomy in posthemorrhoidectomy pain relief: a meta-analysis



This study aims to evaluate the pain relief function of chemical sphincterotomy in patients undergoing haemorrhoid surgery and compare, through a meta-analysis, the different drugs used to treat this condition.


We conducted a search in databases including PubMed, EMBASE and Web of Science. The methodological quality was evaluated using the Revised Cochrane risk-of-bias tool for randomized trials (ROB2). The pain score was assessed using a visual analogue scale (VAS) on day 1, day 2, and day 7, and a meta-analysis was conducted based on the use of random effects models. In addition, the subgroup analysis was evaluated based on the kind of experimental drugs. Heterogeneity and publication bias were assessed.


Fourteen studies with a total of 681 patients were included in this meta-analysis, and all studies were randomized controlled trials RCTs. Chemical sphincterotomy showed better pain relief function than placebo on day 1 (SMD: 1.16, 95% CI 0.52 to 1.80), day 2 (SMD: 2.12, 95% CI 1.37 to 2.87) and day 7 (SMD: 1.97, 95% CI 1.17 to 2.77) after surgery. In the subgroup meta-analysis, we found that different drugs for chemical sphincterotomy provided different pain relief.


Chemical sphincterotomy effectively relieves pain after haemorrhoidectomy, and calcium channel blockers have the best effect.

Peer Review reports


Haemorrhoid is one of the most common anal diseases in the world, and it is estimated that the lifetime risk of developing haemorrhoids in the general population may be as high as 75% [1]. Surgical treatment remains the primary modality indicated for high-grade haemorrhoids [2]. Postoperative pain, which generally results from a spasm of the internal anal sphincter, causes many issues for patients and is the main problem that decreases the postoperative satisfaction of patients [3]. To relieve the postoperative pain caused by spasm of the internal anal sphincter, patients often try to have the internal anal sphincter damaged, including through an internal sphincterotomy [4] or a chemical sphincterotomy through some drugs [5]. Internal sphincterotomy destroys the normal tissue of patients and may cause extra damage to them, which could induce faecal incontinence [6]. On the other hand, chemical sphincterotomy, which can reduce internal anal sphincter spasm, is safer [3, 7]. The drugs that are used for chemical sphincterotomy include calcium channel blocker (CCB), glyceryl trinitrate (GTN), and botulinum toxin (BTX). The function of chemical sphincterotomy in anal fissures is effective based on the latest research [8,9,10]. Some meta-analysis studies have demonstrated the effect of CCB [11] and GTN [12, 13] on the pain relief function of patients who underwent haemorrhoidectomy. However, few studies have studied chemical sphincterotomy by combining all the types of drugs for pain relief after haemorrhoidectomy. To elucidate whether chemical sphincterotomy can decrease the pain of patients after haemorrhoidectomy, we conducted this meta-analysis.


This meta-analysis is reported in accordance with the Preferred Reporting Items of the Systematic Review and Meta-Analysis (PRISMA) statement and is registered in the International Prospective Register of Systematic Reviews (PROSPERO, No. CRD42022357493).

Search strategy

A comprehensive search of published studies was performed in PubMed, Embase and Web of Science. We combined the text word ("haemorrhoids" or "haemorrhoid") with (“calcium channel blocker” or “diltiazem” or “nifedipine”) OR (“glyceryl trinitrate” or "nitroglycerin" or “GTN”) OR ("botulinum toxin" or "BTX") OR ("chemical sphincterotomy"). No language restriction was applied. We did not perform any manual searches, and we did not contact the authors for unpublished relevant data.

Eligibility criteria

Study selection was performed based on predefined Participants, Intervention, Comparators, Outcomes, Study design (PICOS) criteria.


Patients underwent hemorrhoidectomy, regardless of kind of surgery, were included.


Any type of chemical sphincterotomy (including CCB, GTN and BTX injection) used as an intervention to release the pain after hemorrhoidectomy (regardless of the number and duration of the treatment) was included.


Trials that compared chemical sphincterotomy versus placebo or other treatment for pain relief (including lidocaine or herbal ointment) were included. Studies comparing the efficacy of different kind of chemical sphincterotomy were excluded.


VAS score was used as the primary outcomes. The studies should report VAS score at least one of the following days after surgery: day1, day2 or day7 after surgery with standard deviation (SD).

Study design

Only randomized controlled trials (RCTs) were included. Dissertations, theses, guidelines, conference abstracts and narrative reviews were excluded.

Studies not meeting the criteria, studies without data for retrieval and duplicate publications were excluded. When two papers reported the same study, the publication that was more informative was selected.

Data extraction

Two researchers (CYF and MMY) independently extracted data from the included studies by scrutinizing the full text and determining the methodological quality of all eligible studies. Disagreements were resolved by discussion or consensus or with a third reviewer (LY). The following information was collected from the eligible articles: authors, year of publication, location, number of patients with or without chemical sphincterotomy, kind of experimental drug use, patient age, sex, operation approach, and VAS score on days 1, 2, and 7 after surgery.

Quality assessment

Three researchers (CYF, MMY and LY) used the ROB2 independently to assess the quality of RCTs [14]. Bias was assessed as a judgment (high, low, or some concerns) for elements from five domains: (1) randomization process; (2) deviations from intended interventions; (3) missing outcome data; (4) measurement of the outcome; and (5) selection of the reported result.

Statistical analysis

The mean VAS score and SD of each study were collected and calculated using a random-effects model if the heterogeneity was considerable, and a fixed-effects model was performed otherwise. Heterogeneity analysis was performed by calculating the I2 index. We assessed the possibility of publication bias by Egger’s test. All statistical analyses were carried out using R version 4.2.0 software.


Literature search

Figure 1 shows the search process, which yielded a total of 590 citations using the search strategy. After excluding 65 duplicate and 525 irrelevant articles based on the abstracts or titles, we finally included 36 citations for detailed evaluation. After full-text reading, 14 studies matched our inclusion criteria and were included in our meta-analysis.

figure 1

Flow chart showing the selection process for the included studies

Study characteristics

The characteristics of the 14 selected studies are presented in Table 1. These studies provide data on the VAS score of patients on different days after haemorrhoidectomy. All 14 studies were RCTs, and all of them were published after 2000. The experimental drug used in 5 of the studies was CCB ointment [15,16,17,18,19], in 7 of the studies, it was GTN ointment [20,21,22,23,24,25,26], and only 2 studies used BTX injection [27, 28], the administration was not same in different studies, CCB and GTN were applied to the perianal area at different frequencies daily after surgery, while BTX was injected into the intersphincteric space immediately after excision before closing the wound [27, 28]. All studies chose placebo drug in control group except 1 study [22] which used 2.5% lidocaine instead, all studies used the VAS score to evaluate the pain of patients. In the selection of operation, 7 studies included patients who underwent Milligan-Morgan haemorrhoidectomy [15, 17, 18, 20, 24, 26, 28], 4 studies chose Ferguson haemorrhoidectomy [19, 21, 23, 27], 1 study chose stapled haemorrhoidopexy [22], and 2 studies did not mention the surgery technique [16, 25].

Table 1 Baseline characteristics of the included studies

Risk of bias

Figure 2 shows the detailed results of risk of bias. 9 studies had low risk of bias, 3 studies had some concerns of bias risk and 2 studies had high of bias risk. The risk of bias occurring during the randomization process had some concerns in 4 studies [16, 18, 21, 29] due to an uncertain randomization sequence, 1 study [24] did not mention blinding methods and 1 study [27] was categorized as having a high risk of measurement of the outcome because therapists knew the group they were treating.

Fig. 2
figure 2

The risk of bias assessment


Postoperative pain was assessed in 14 studies through a 10-point VAS (0 = no pain, 10 = severe pain). The measured outcomes on days 1, 2 and 7 after the operation were compared because of the variation in the pain assessment time among the studies. The pooled standardized mean difference (SMD) in the degree of pain score was 1.16 (95% CI 0.52 to 1.80, I2 = 90%) on day 1 (Fig. 3A), 2.12 (95% CI 1.37 to 2.87, I2 = 88%) on day 2 (Fig. 3B), and 1.97 (95% CI 1.17 to 2.77, I2 = 89%) on day 7 (Fig. 3C) after the operation.

Fig. 3
figure 3

Forest plot based on VAS score on Days 1, 2 and 7 after surgery

Subgroup meta-analysis

We performed subgroup analysis according to the kind of drug use. On day 1, the patients treated with CCB (SMD = 1.81, 95% CI 0.98 to 2.63, I2 = 69%), BTX (SMD = 0.65, 95% CI 0.28 to 1.03, I2 = 0%) or GTN (SMD = 1.06, 95% CI 0.04 to 2.07, I2 = 93%) showed lower pain scores than each control group, and CCB showed better pain relief function than the other two drugs (Fig. 4). The same results were shown on day 2 (Fig. 5) and day 7 (Fig. 6). On day 2, the patients treated with CCB (SMD = 2.79, 95% CI 2.16 to 3.41, I2 = 59%) showed lower pain scores than those treated with GTN (SMD = 1.97, 95% CI 1.35 to 2.58, I2 = 50%), and the patients treated with BTX (SMD = 0, 95% CI -0.69 to 0.69) had no significant difference in pain scores compared with those who were not treated with BTX. On day 7, the patients treated with CCB (SMD = 2.09, 95% CI 1.52 to 2.65, I2 = 15%) showed lower pain scores than the patients in the control group, while those treated with GTN (SMD = 1.21, 95% CI -0.20 to 2.62, I2 = 92%) and BTX (SMD = -0.66, 95% CI -1.37 to 0.06) had no significant difference in pain scores compared with those who were not treated with these medications.

Fig. 4
figure 4

Subgroup meta-analysis on Day 1 after surgery

Fig. 5
figure 5

Subgroup meta-analysis on Day 2 after surgery

Fig. 6
figure 6

Subgroup meta-analysis on Day 7 after surgery

Publication bias

We detected publication bias based on Egger’s test in this study. As shown in Table 2, every p value of day 1, day 2 and day 7 was larger than 0.05, which means that there was no significant publication bias in our meta-analysis.

Table 2 Publication bias of meta-analysis


Haemorrhoids are a common disease that causes patient inconvenience in life and work and are divided into internal and external haemorrhoids. Mixed haemorrhoids are a mixture of internal and external haemorrhoids, and the most common symptoms of mixed haemorrhoids are bleeding, prolapse, perianal itching, pain and sometimes anaemia secondary to haemorrhage [30]. For mixed haemorrhoids, the treatment options include conservative treatment and surgical treatment. Surgery is the initial treatment of choice in patients with symptomatic grade III–IV haemorrhoids [31]; however, recovering from haemorrhoid surgery is difficult for most patients. This is because after surgery, especially excisional haemorrhoidectomy, postoperative pain, which generally results from a spasm of the internal anal sphincter, causes many issues for patients [2]. For the treatment of postoperative pain in patients after haemorrhoidectomy, people often choose different methods, such as sitz baths [29], medications to reduce swelling [32] or topical anaesthesia [33]. Chemical sphincterotomy, which is always used for patients with anal fissures, can reduce spasms of the internal anal sphincter and relieve pain [34]. Compared with lateral internal sphincterotomy, chemical sphincterotomy, although slightly inferior in analgesic effect, is more advantageous in regard to complications such as faecal incontinence [35]. The most common agents used for chemical sphincterotomy are CCB, GTN and BTX, which have different mechanisms to achieve the desired effects. CCB can reduce myocyte uptake of calcium ions, thus decreasing sphincter contraction or spasm [3]. GTN is a nitric oxide donor and thus aids in the relaxation of the internal sphincter. GTN may also increase blood flow and help in the healing process [36]. BTX, which is produced by the Clostridium botulinum anaerobic bacterium, functions by preventing the secretion of acetylcholine that causes neuromuscular blockage and muscle paralysis [37]. Because of the efficacy of chemical sphincterotomy in anal fissures, doctors pay attention and treat posthemorrhoidectomy pain by using chemical sphincterotomy, and it has been indicated that chemical sphincterotomy also has a good effect after haemorrhoid surgery in pain relief [5].

Our meta-analysis assessed whether chemical sphincterotomy can relieve posthemorrhoidectomy pain. This study included 681 participants from 14 cohort studies and had no significant publication bias based on the results of Egger’s test (all p > 0.05). In our study, we proved that on days 1, 2, and 7 after surgery, the patients treated with chemical sphincterotomy had lower VAS score than those treated with placebo. The difference between these two groups was significant; however, the studies included in our analysis displayed considerable heterogeneity, which may be because of the different surgical approaches and different kinds of experimental drugs. In our selected studies, the surgical approaches included Milligan-Morgan, Ferguson, and stapled haemorrhoidopexy, and different kinds of surgery led to different degrees of pain [2], thus resulting in high heterogeneity. On the other hand, CCB, GTN and BTX also have different effectiveness for pain relief [38]. To compare the differences between these three drugs, we conducted a subgroup meta-analysis. In the subgroup meta-analysis, the heterogeneity decreased in each subgroup, and we found that on days 1, 2 and 7 after surgery, CCB showed better pain relief function than GTN and BTX, indicating that CCB may be a better drug to relieve posthemorrhoidectomy pain caused by spasms of the internal anal sphincter. In an RCT for children who suffered from anal fissures, CCB was more effective and safer than GTN and lidocaine [39], which is consistent with our results above. BTX is injected once into the intersphincteric region of patients immediately after excision [27]. Patients will not receive BTX injection later, and the duration of BTX function may not last long, which may be the reason that BTX only showed pain relief function on Day 1 in our subgroup analysis.

Chemical sphincterotomy also has some shortcomings, such as headache and other side effects, especially when using GTN. Among the studies we included, 4 studies recorded that patients had headaches after using GTN [22, 23, 25, 26], but the headaches could be relieved by dose reduction, which could relieve the headache effectively while having little influence on spasm relief [22] or could be relieved by some medications, such as anti-inflammatory drugs (NAISDs) [23] or prednisolone [40]. Chemical sphincterotomy will also improve the risk of incontinence compared with the use of placebo, but compared with internal sphincterotomy, the incontinence caused by chemical sphincterotomy is less [3]. Moreover, the incontinence is reversible, which means that patients can stop suffering from it when they stop the drug treatment, which is a safer alternative.

There are also several limitations in our study. First, as we have mentioned above, the surgical techniques and the experimental drug dosage application differed across all studies, which resulted in high heterogeneity. Although we conducted a subgroup meta-analysis based on the kind of experimental drug and partly decreased the heterogeneity, in some subgroups, the heterogeneity was still high. Second, the sample size of some trials was small. Silverman’s study [16] only included 9 patients in each observation group and control group, and further research should be conducted, especially studies with a large number of research bases and well-designed RCTs for specific patients.

In conclusion, our study revealed that chemical sphincterotomy application after haemorrhoidectomy significantly decreases pain compared with a placebo. In the comparison of the three experimental drugs, CCB showed better pain relief function than GTN and BTX. As a result, patients can be given CCB ointment after haemorrhoidectomy to help relieve pain.

Availability of data and materials

The data that support the findings of this study are available from the first author (Yifan Cheng) upon reasonable request.


  1. Lohsiriwat V. Treatment of hemorrhoids: A coloproctologist’s view. World J Gastroenterol. 2015;21(31):9245–52.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Chen Y, Cheng Y, Wang Q, et al. Modified procedure for prolapse and hemorrhoids: Lower recurrence, higher satisfaction. World J Clin Cases. 2021;9(1):36–46.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Chauhan A, Tiwari S, Mishra V, Bhatia P. Comparison of internal sphincterotomy with topical diltiazem for post-hemorrhoidectomy pain relief: a prospective randomized trial. J Postgrad Med. 2009;55(1):22–6.

    Article  CAS  PubMed  Google Scholar 

  4. Asfar S, Juma T, Ala-Edeen T. Hemorrhoidectomy and sphincterotomy. A prospective study comparing the effectiveness of anal stretch and sphincterotomy in reducing pain after hemorrhoidectomy. Dis Colon Rectum. 1988;31(3):181–5.

    Article  CAS  PubMed  Google Scholar 

  5. Siddiqui M, Abraham-Igwe C, Shangumanandan A, et al. A literature review on the role of chemical sphincterotomy after Milligan-Morgan hemorrhoidectomy. Int J Colorectal Dis. 2011;26(6):685–92.

    Article  PubMed  Google Scholar 

  6. Hosseini S, Sharifi K, Ahmadfard A, et al. Role of internal sphincterotomy in the treatment of hemorrhoids: a randomized clinical trial. Arch Iran Med. 2007;10(4):504–8.

    PubMed  Google Scholar 

  7. Mishra R, Thomas S, Maan M, Hadke N. Topical nitroglycerin versus lateral internal sphincterotomy for chronic anal fissure: prospective, randomized trial. ANZ J Surg. 2005;75(12):1032–5.

    Article  PubMed  Google Scholar 

  8. Barbeiro S, Atalaia-Martins C, Marcos P, et al. Long-term outcomes of Botulinum toxin in the treatment of chronic anal fissure: 5 years of follow-up. United European Gastroenterol J. 2017;5(2):293–7.

    Article  CAS  PubMed  Google Scholar 

  9. Giridhar CM, Preethitha B, K. Seshagiri Rao. A Comparative Study of Lateral Sphincterotomy and 2% Diltiazem Gel Local Application in the Treatment of Chronic Fissure in ANO. J Clin Diagn Res. 2014;8(10):01–02.

  10. Tauro L, Shindhe V, Aithala P, et al. Comparative study of glyceryl trinitrate ointment versus surgical management of chronic anal fissure. Indian J Surg. 2011;73(4):268–77.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Huang YJ, Chen CY, Chen RJ, et al. Topical diltiazem ointment in post-hemorrhoidectomy pain relief: A meta-analysis of randomized controlled trials. Asian J Surg. 2018;41(5):431–7.

    Article  PubMed  Google Scholar 

  12. Ratnasingham K, Uzzaman M, Andreani SM, et al. Meta-analysis of the use of glyceryl trinitrate ointment after haemorrhoidectomy as an analgesic and in promoting wound healing. Int J Surg. 2010;8(8):606–11.

    Article  CAS  PubMed  Google Scholar 

  13. Liu JW, Lin CC, Kiu KT, et al. Effect of Glyceryl Trinitrate Ointment on Pain Control After Hemorrhoidectomy: A Meta-analysis of Randomized Controlled Trials. World J Surg. 2016;40(1):215–24.

    Article  PubMed  Google Scholar 

  14. Higgins J, D Altman, P Gøtzsche, et al The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343(d5928).

  15. Yadav S, Khandelwal RG, Om P, et al. A prospective randomized double-blind study of pain control by topical calcium channel blockers versus placebo after Milligan-Morgan hemorrhoidectomy. Int J Colorectal Dis. 2018;33(7):895–9.

    Article  PubMed  Google Scholar 

  16. Silverman R, Bendick PJ, Wasvary HJ. A randomized, prospective, double-blind, placebo-controlled trial of the effect of a calcium channel blocker ointment on pain after hemorrhoidectomy. Dis Colon Rectum. 2005;48(10):1913–6.

    Article  PubMed  Google Scholar 

  17. Amoli HA, Notash AY, Shahandashti FJ, et al. A randomized, prospective, double-blind, placebo-controlled trial of the effect of topical diltiazem on posthaemorrhoidectomy pain. Colorectal Dis. 2011;13(3):328–32.

    Article  CAS  PubMed  Google Scholar 

  18. Suchdev S, Ghayassuddin M, Younus SM, et al. Calcium Channel Blockers for pain relief after Haemorrhoidectomy; a randomized controlled trial from Karachi, Pakistan. Pak J Surg. 2014;30(2):187–92.

    Google Scholar 

  19. Rodríguez-Wong U, Ocharán-Hernández ME, Toscano-Garibay J. Topical diltiazem for pain after closed hemorrhoidectomy. Rev Gastroenterol Mex. 2016;81(2):74–9.

    PubMed  Google Scholar 

  20. Vahabi S, Beiranvand S, Karimi A, Moradkhani M. Comparative Study of 0.2% Glyceryl Trinitrate Ointment for Pain Reduction after Hemorrhoidectomy Surgery. Surg J (N Y). 2019;5(4):e192–6.

    Article  PubMed  Google Scholar 

  21. Wasvary HJ, Hain J, Mosed-Vogel M, et al. Randomized, prospective, double-blind, placebo-controlled trial of effect of nitroglycerin ointment on pain after hemorrhoidectomy. Dis Colon Rectum. 2001;44(8):1069–73.

    Article  CAS  PubMed  Google Scholar 

  22. Mari FS, Nigri G, Dall’Oglio A, et al. Topical glyceryl trinitrate ointment for pain related to anal hypertonia after stapled hemorrhoidopexy: a randomized controlled trial. Dis Colon Rectum. 2013;56(6):768–73.

    Article  PubMed  Google Scholar 

  23. Karanlik H, Akturk R, Camlica H, Asoglu O. The effect of glyceryl trinitrate ointment on posthemorrhoidectomy pain and wound healing: results of a randomized, double-blind, placebo-controlled study. Dis Colon Rectum. 2009;52(2):280–5.

    Article  PubMed  Google Scholar 

  24. Di Vita G, Patti R, Arcara M, et al. A painless treatment for patients undergoing Milligan-Morgan haemorrhoidectomy. Ann Ital Chir. 2004;75(4):471–5.

    PubMed  Google Scholar 

  25. Hwang DY, Yoon SG, Kim HS, et al. Effect of 0.2 percent glyceryl trinitrate ointment on wound healing after a hemorrhoidectomy: results of a randomized, prospective, double-blind, placebo-controlled trial. Dis Colon Rectum. 2003;46(7):950–4.

    Article  PubMed  Google Scholar 

  26. Patti R, Arcara M, Padronaggio D, et al. Efficacy of topical use of 0.2% glyceryl trinitrate in reducing post-haemorrhoidectomy pain and improving wound healing. Chir Ital. 2005;57(1):77–85.

    PubMed  Google Scholar 

  27. Sirikurnpiboon S, Jivapaisarnpong P. Botulinum Toxin Injection for Analgesic Effect after Hemorrhoidectomy: A Randomized Control Trial. J Anus Rectum Colon. 2020;4(4):186–92.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Singh B, Box B, Lindsey I, et al. Botulinum toxin reduces anal spasm but has no effect on pain after haemorrhoidectomy. Colorectal Dis. 2009;11(2):203–7.

    Article  CAS  PubMed  Google Scholar 

  29. Zeng A, Gu G, Deng L. Effect of Kangfuxin Solution Fumigation Bath on Postoperative Patients with Hemorrhoid PPH and Influence on the Postoperative Complications. Evid Based Complement Alternat Med. 2021;6473754:2021.

    Google Scholar 

  30. Parés D, Abcarian H. Management of Common Benign Anorectal Disease: What All Physicians Need to Know. Am J Med. 2018;131(7):745–51.

    Article  PubMed  Google Scholar 

  31. Hollingshead J, Phillips R. Haemorrhoids: modern diagnosis and treatment. Postgrad Med J. 2016;92(1083):4–8.

    Article  CAS  PubMed  Google Scholar 

  32. Lin S, Zang M. Effectiveness of Mayinglong Musk Hemorrhoid Ointment on Wound Healing and Complications after Internal Hemorrhoid Ligation and External Hemorrhoidectomy. Evid Based Complement Alternat Med. 2022;5630487:2022.

    Google Scholar 

  33. Linares-Gil M, Valls J, Hereu-Boher P, et al. Topical Analgesia with Lidocaine Plus Diclofenac Decreases Pain in Benign Anorectal Surgery: Randomized, Double-blind, and Controlled Clinical Trial. Clin Transl Gastroenterol. 2018;9(11):210.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Pardhan A, R Azami, S Mazahir, G Murtaza. Diltiazem vs. glyceryl tri-nitrate for symptomatic relief in anal fissure: a randomised clnical study. J Pak Med Assoc. 2014;64(5):510–3.

  35. Brady J, Althans A, Neupane R, et al. Treatment for anal fissure: Is there a safe option? Am J Surg. 2017;214(4):623–8.

    Article  PubMed  Google Scholar 

  36. Jones O. Towards safer treatments for benign anorectal disease: the pharmacological manipulation of the internal anal sphincter. Ann R Coll Surg Engl. 2007;89(6):574–9.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Carter D, Dickman R. The Role of Botox in Colorectal Disorders. Curr Treatment Options Gastroenterology. 2018;16(4):541–7.

    Article  Google Scholar 

  38. Patti R, Angileri M, Migliore G, et al. Effectiveness of contemporary injection of botulinum toxin and topical application of glyceryl trinitrate against postoperative pain after Milligan-Morgan haemorrhoidectomy. Ann Ital Chir. 2006;77(6):503–8.

    PubMed  Google Scholar 

  39. Cevik M, Boleken M, Koruk I, et al. A prospective, randomized, double-blind study comparing the efficacy of diltiazem, glyceryl trinitrate, and lidocaine for the treatment of anal fissure in children. Pediatr Surg Int. 2012;28(4):411–6.

    Article  PubMed  Google Scholar 

  40. Tfelt-Hansen P, Daugaard D, Lassen L, et al. Prednisolone reduces nitric oxide-induced migraine. Eur J Neurol. 2009;16(10):1106–11.

    Article  CAS  PubMed  Google Scholar 

Download references


Not applicable.


This work was supported by the foundation of Science and Technology Bureau of TaiZhou (1902ky04).

Author information

Authors and Affiliations



Yifan Cheng and Misha Mao extracted data from the included studies by scrutinizing the full text and determining the methodological quality of all eligible studies, performed most of the data analysis and wrote this paper; Yaqian Shang, Chaomei Ying and Linnan Guo serached the ariticles in Pubmed, Embase and Web of Science, and made Tables. Yong Lu resolved the disagreements and was responsible for the reliability of the statements made in the paper. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Yong Lu.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheng, Y., Mao, M., Shang, Y. et al. Chemical sphincterotomy in posthemorrhoidectomy pain relief: a meta-analysis. BMC Surg 23, 113 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Chemical sphincterotomy
  • Haemorrhoidectomy
  • Calcium channel blockers
  • Glyceryl trinitrate
  • Botulinum toxin
  • Postoperative pain